beta

ACIU

AC Immune SA

Aciu

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

AC Immune SA is a clinical stage biopharmaceutical company. It discovers, designs and develops novel, proprietary medicines for treatment of neurodegenerative diseases with the help of proprietary platforms.

Market Cap: 770 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.acimmune.com

Shares Outstanding: 56.9 Million

Float: 56.9 Million

Dividend: 0.0 (0.0%)

Beta: 1.70028

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 1.76 Million

Ethical Flags

Animal testing

Longest drawdown: 766 trading days

From: 2016-09-28 To: 2019-10-11

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud